Product Information
VALGANCICLOVIR HCL 50 MG/ML is a generic product labeled by Florida Pharmaceutical Products, LLC, priced at $1.0058 per ML under NDC 71921021012. Its NADAC has been published 132 times since Aug 30, 2023.
FDA first approved this application on Apr 11, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/mL
Manufacturer
Florida Pharmaceutical Products, LLCNDC
71921021012
Classification
Generic
Dosage Form
POWDER, FOR SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALGANCICLOVIRApproval Type
Generic (ANDA)
FDA Application
ANDA216317FDA Approved
4/11/2023
TE Code
AB
On Market Since
7/1/2023
Pharmacological Classes
Price Statistics
The NADAC for VALGANCICLOVIR HCL 50 MG/ML has been published 132 times since Aug 30, 2023, and over the history we have for it it has declined 79.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0058 per ML |
|---|---|
| All-time high | $4.9284 (Sep 13, 2023) |
| All-time low | $0.9898 (Aug 19, 2026) |
| 52-week high | $1.4406 |
| 52-week low | $0.9898 |
| Median price | $1.9639 |
| Average price | $1.9726 |
| Largest weekly change | -30.0% (Apr 17, 2024) |
| Weeks tracked | 132 |
| Tracking since | Aug 30, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Valganciclovir market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Florida Pharmaceutical Products, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Valganciclovir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALGANCICLOVIR HCL 50 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for VALGANCICLOVIR HCL 50 MG/ML, manufactured by Florida Pharmaceutical Products, LLC, is $1.0058 per ML (NDC 71921021012), effective Sep 30, 2026.
How has the price of VALGANCICLOVIR HCL 50 MG/ML changed over time?
Over the history we have for it, the NADAC for VALGANCICLOVIR HCL 50 MG/ML has declined 79.6%. It has been tracked across 132 weekly CMS publications since Aug 30, 2023.
What are the highest and lowest recorded NADAC prices for VALGANCICLOVIR HCL 50 MG/ML?
Since Aug 30, 2023, the NADAC for VALGANCICLOVIR HCL 50 MG/ML has ranged from a low of $0.9898 (Aug 19, 2026) to a high of $4.9284 (Sep 13, 2023), with a median of $1.9639 per ML.
Are there cheaper alternatives to VALGANCICLOVIR HCL 50 MG/ML?
No other NADAC-published product currently shares the active ingredient and strength of VALGANCICLOVIR HCL 50 MG/ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VALGANCICLOVIR HCL 50 MG/ML?
VALGANCICLOVIR HCL 50 MG/ML (NDC 71921021012) is labeled by Florida Pharmaceutical Products, LLC, and CMS classifies it as a generic product.